HKeyBio has established HKEY-AI-NAM-Bridge™ 1.0, its AI and New Approach Methodologies (NAMs) In Vivo Evidence Bridging Package. The service helps autoimmune and allergy drug-development teams ...
HKeyBio has established HKEY-AI-NAM-Bridgetm 1.0, its AI and New Approach Methodologies (NAMs) In Vivo Evidence Bridging Package. The service helps autoimmune and allergy drug-development teams ...
Lipid nanoparticles (LNPs) have emerged as a leading platform for nucleic acid delivery; however, their inherent tendency to accumulate in the liver continues to limit broader therapeutic applications ...
Patients exposed to vitamin D showed significantly longer treatment-free survival than nonusers, with median durations of 147 vs 82 months.
New 2026 research on 354,957 people links 5 daily cups of coffee to a 47% lower liver cancer risk and 32% reduced cirrhosis ...
MindWalk Holdings Corp. ("MindWalk" or the "Company") , a Bio-Native AI company, today announced that it will report financial results for the fourth quarter and full fiscal year 2026 and host a ...
A practical guide for small teams to standardize office software, file formats, templates, folder structures, version control ...